SOD1 and amyotrophic lateral sclerosis: In the present pilot study, we used transdifferentiated astrocytes from patients with sALS and SOD1 mutations (mSOD1-ALS) to verify their neurotoxic nature, and to assess differences in the cell line signatures for astrocyte reactive markers and miRNAs associated with inflammation.